Urothelial Bladder Cancer — Fifth Annual National General Medical Oncology Summit
About this episode
The episode discusses immunotherapeutic strategies and emerging treatments for urothelial bladder cancer with insights from two experts in the field.
Featuring perspectives from Dr Terence Friedlander and Dr Daniel P Petrylak, including the following topics: Introduction (0:00) Role of Immunotherapeutic Strategies in the Management of Nonmetastatic Urothelial Bladder Cancer (UBC); Emerging Utility of Circulating Tumor DNA Evaluation — Dr Friedlander (3:53) Other Novel Agents and Strategies for Nonmetastatic and Metastatic UBC — Dr Petrylak (26:41) CME information and select publications
More episodes of Prostate Cancer Update
- Androgen Deprivation Therapy for Prostate Cancer — An Interview with Dr Rana R McKay
- For Oncology Nurses: Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Proceedings from the 2026 Annual ONS Congress
- Urothelial Bladder Cancer — Year in Review Series on Relevant New Datasets and Advances
- Prostate Cancer — Fifth Annual National General Medical Oncology Summit
- Prostate Cancer — Proceedings from a Session Held in Conjunction with the 2026 American Urological Association Annual Meeting
Explore listener stats, chart rankings, contacts and more on the Prostate Cancer Update podcast page.